nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0458	0.257	CbGeAlD
Orphenadrine—GRIN2D—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.028	0.0359	CbGpPWpGaD
Orphenadrine—GRIN2D—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0249	0.032	CbGpPWpGaD
Orphenadrine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0229	0.0295	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0224	0.0288	CbGpPWpGaD
Orphenadrine—GRIN1—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.02	0.0257	CbGpPWpGaD
Orphenadrine—GRIN1—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.0178	0.0229	CbGpPWpGaD
Orphenadrine—KCNH2—Potassium Channels—KCNJ5—adrenal gland cancer	0.0176	0.0227	CbGpPWpGaD
Orphenadrine—CYP2E1—urine—adrenal gland cancer	0.0173	0.0975	CbGeAlD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0168	0.0217	CbGpPWpGaD
Orphenadrine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0164	0.0211	CbGpPWpGaD
Orphenadrine—GRIN2D—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0163	0.021	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.016	0.0206	CbGpPWpGaD
Orphenadrine—CYP3A4—urine—adrenal gland cancer	0.014	0.0784	CbGeAlD
Orphenadrine—GRIN1—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.0139	0.0179	CbGpPWpGaD
Orphenadrine—GRIN2D—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.0134	0.0172	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—KCNJ5—adrenal gland cancer	0.0129	0.0166	CbGpPWpGaD
Orphenadrine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.0124	0.0159	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0121	0.0155	CbGpPWpGaD
Orphenadrine—GRIN1—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.0117	0.015	CbGpPWpGaD
Orphenadrine—SCN9A—pituitary gland—adrenal gland cancer	0.0113	0.0637	CbGeAlD
Orphenadrine—SCN9A—adrenal gland—adrenal gland cancer	0.0101	0.0569	CbGeAlD
Orphenadrine—SCN4A—pituitary gland—adrenal gland cancer	0.0101	0.0568	CbGeAlD
Orphenadrine—CHRM2—GPCRs, Other—GNRHR—adrenal gland cancer	0.01	0.0129	CbGpPWpGaD
Orphenadrine—GRIN1—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00961	0.0124	CbGpPWpGaD
Orphenadrine—SCN5A—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.0094	0.0121	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—KCNJ5—adrenal gland cancer	0.00924	0.0119	CbGpPWpGaD
Orphenadrine—SCN4A—adrenal gland—adrenal gland cancer	0.00903	0.0507	CbGeAlD
Orphenadrine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00885	0.0114	CbGpPWpGaD
Orphenadrine—SCN10A—pituitary gland—adrenal gland cancer	0.00863	0.0485	CbGeAlD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00858	0.011	CbGpPWpGaD
Orphenadrine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00845	0.0109	CbGpPWpGaD
Orphenadrine—Reboxetine—ABCB1—adrenal gland cancer	0.00822	0.186	CrCbGaD
Orphenadrine—GRIN2D—Alzheimers Disease—BAD—adrenal gland cancer	0.00803	0.0103	CbGpPWpGaD
Orphenadrine—SCN5A—cardiac atrium—adrenal gland cancer	0.00803	0.0451	CbGeAlD
Orphenadrine—KCNH2—Neuronal System—KCNJ5—adrenal gland cancer	0.0077	0.0099	CbGpPWpGaD
Orphenadrine—Fenoprofen—PTGS2—adrenal gland cancer	0.00722	0.163	CrCbGaD
Orphenadrine—GRIN1—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00717	0.00922	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—NR5A1—adrenal gland cancer	0.00706	0.00907	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.00677	0.0087	CbGpPWpGaD
Orphenadrine—Toremifene—ABCB1—adrenal gland cancer	0.00652	0.147	CrCbGaD
Orphenadrine—SCN4A—Developmental Biology—NR5A1—adrenal gland cancer	0.00648	0.00834	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00645	0.0083	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—NR5A1—adrenal gland cancer	0.00625	0.00804	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—NR5A1—adrenal gland cancer	0.00625	0.00804	CbGpPWpGaD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00615	0.00791	CbGpPWpGaD
Orphenadrine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00613	0.00789	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.00598	0.00769	CbGpPWpGaD
Orphenadrine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00584	0.00751	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—BAD—adrenal gland cancer	0.00575	0.0074	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00573	0.00737	CbGpPWpGaD
Orphenadrine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00572	0.00736	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00564	0.00725	CbGpPWpGaD
Orphenadrine—SLC6A2—gonad—adrenal gland cancer	0.0055	0.0309	CbGeAlD
Orphenadrine—Fluoxetine—ABCB1—adrenal gland cancer	0.00515	0.116	CrCbGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00513	0.00659	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—NR5A1—adrenal gland cancer	0.00511	0.00658	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—CDC42—adrenal gland cancer	0.0051	0.00656	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—PRKACA—adrenal gland cancer	0.00494	0.00636	CbGpPWpGaD
Orphenadrine—KCNH2—cardiac atrium—adrenal gland cancer	0.00494	0.0277	CbGeAlD
Orphenadrine—CYP2B6—adrenal cortex—adrenal gland cancer	0.0049	0.0275	CbGeAlD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00485	0.00623	CbGpPWpGaD
Orphenadrine—KCNH2—pituitary gland—adrenal gland cancer	0.00482	0.0271	CbGeAlD
Orphenadrine—SLC6A2—adrenal gland—adrenal gland cancer	0.0048	0.0269	CbGeAlD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0047	0.00604	CbGpPWpGaD
Orphenadrine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00463	0.00595	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00462	0.00594	CbGpPWpGaD
Orphenadrine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00462	0.00594	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—NR5A1—adrenal gland cancer	0.0044	0.00565	CbGpPWpGaD
Orphenadrine—KCNH2—adrenal gland—adrenal gland cancer	0.00431	0.0242	CbGeAlD
Orphenadrine—SCN9A—Developmental Biology—MED12—adrenal gland cancer	0.00424	0.00545	CbGpPWpGaD
Orphenadrine—CYP2B6—gonad—adrenal gland cancer	0.00406	0.0228	CbGeAlD
Orphenadrine—SCN4A—Developmental Biology—MED12—adrenal gland cancer	0.0039	0.00501	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0038	0.00488	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MED12—adrenal gland cancer	0.00376	0.00483	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MED12—adrenal gland cancer	0.00376	0.00483	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00374	0.0048	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—RB1—adrenal gland cancer	0.00373	0.0048	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—CDC42—adrenal gland cancer	0.00368	0.00473	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—BAD—adrenal gland cancer	0.00356	0.00458	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—PRKACA—adrenal gland cancer	0.00354	0.00455	CbGpPWpGaD
Orphenadrine—SCN9A—L1CAM interactions—EGFR—adrenal gland cancer	0.00354	0.00455	CbGpPWpGaD
Orphenadrine—CYP2B6—adrenal gland—adrenal gland cancer	0.00353	0.0199	CbGeAlD
Orphenadrine—GRIN2D—Alzheimers Disease—TP53—adrenal gland cancer	0.00352	0.00452	CbGpPWpGaD
Orphenadrine—HRH1—IL-4 Signaling Pathway—BAD—adrenal gland cancer	0.00351	0.00452	CbGpPWpGaD
Orphenadrine—GRIN2D—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00348	0.00447	CbGpPWpGaD
Orphenadrine—HRH1—adrenal gland—adrenal gland cancer	0.00345	0.0194	CbGeAlD
Orphenadrine—HRH1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00344	0.00442	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—CDC42—adrenal gland cancer	0.00338	0.00434	CbGpPWpGaD
Orphenadrine—CYP2E1—adrenal gland—adrenal gland cancer	0.00332	0.0186	CbGeAlD
Orphenadrine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00331	0.00426	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—CDC42—adrenal gland cancer	0.00326	0.00419	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—CDC42—adrenal gland cancer	0.00326	0.00419	CbGpPWpGaD
Orphenadrine—SCN4A—L1CAM interactions—EGFR—adrenal gland cancer	0.00325	0.00418	CbGpPWpGaD
Orphenadrine—SCN1A—L1CAM interactions—EGFR—adrenal gland cancer	0.00314	0.00403	CbGpPWpGaD
Orphenadrine—SCN10A—L1CAM interactions—EGFR—adrenal gland cancer	0.00314	0.00403	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MED12—adrenal gland cancer	0.00307	0.00395	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00307	0.00395	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.00307	0.00395	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—PRKACA—adrenal gland cancer	0.00295	0.00379	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00289	0.00372	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00285	0.00366	CbGpPWpGaD
Orphenadrine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00279	0.00358	CbGpPWpGaD
Orphenadrine—Trimipramine—ABCB1—adrenal gland cancer	0.00272	0.0615	CrCbGaD
Orphenadrine—GRIN1—Axon guidance—CDC42—adrenal gland cancer	0.00267	0.00343	CbGpPWpGaD
Orphenadrine—GRIN2D—Neuronal System—BRAF—adrenal gland cancer	0.00266	0.00343	CbGpPWpGaD
Orphenadrine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00265	0.00341	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MED12—adrenal gland cancer	0.00264	0.0034	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CDC42—adrenal gland cancer	0.00262	0.00337	CbGpPWpGaD
Orphenadrine—Promethazine—ABCB1—adrenal gland cancer	0.00262	0.0592	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—adrenal gland cancer	0.0026	0.0588	CrCbGaD
Orphenadrine—Doxepin—ABCB1—adrenal gland cancer	0.00259	0.0586	CrCbGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.00259	0.00333	CbGpPWpGaD
Orphenadrine—Methadone—ABCB1—adrenal gland cancer	0.00258	0.0583	CrCbGaD
Orphenadrine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00254	0.00327	CbGpPWpGaD
Orphenadrine—GRIN1—Alzheimers Disease—TP53—adrenal gland cancer	0.00252	0.00324	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.0025	0.00321	CbGpPWpGaD
Orphenadrine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00249	0.0032	CbGpPWpGaD
Orphenadrine—GRIN1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00249	0.0032	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CDC42—adrenal gland cancer	0.00241	0.0031	CbGpPWpGaD
Orphenadrine—GRIN1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.00234	0.00301	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CDC42—adrenal gland cancer	0.00233	0.00299	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CDC42—adrenal gland cancer	0.00233	0.00299	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—CDC42—adrenal gland cancer	0.00229	0.00295	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00227	0.00292	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00224	0.00288	CbGpPWpGaD
Orphenadrine—SCN5A—L1CAM interactions—EGFR—adrenal gland cancer	0.0022	0.00284	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.0022	0.00283	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.0022	0.00282	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.00218	0.0028	CbGpPWpGaD
Orphenadrine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.0021	0.0027	CbGpPWpGaD
Orphenadrine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00206	0.00265	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00203	0.00261	CbGpPWpGaD
Orphenadrine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00202	0.0026	CbGpPWpGaD
Orphenadrine—Imipramine—ABCB1—adrenal gland cancer	0.00202	0.0456	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—adrenal gland cancer	0.00201	0.0453	CrCbGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.002	0.00257	CbGpPWpGaD
Orphenadrine—GRIN1—Neuronal System—BRAF—adrenal gland cancer	0.00191	0.00245	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CDC42—adrenal gland cancer	0.0019	0.00245	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00189	0.00243	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00183	0.00235	CbGpPWpGaD
Orphenadrine—GRIN1—Spinal Cord Injury—TP53—adrenal gland cancer	0.00183	0.00235	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00173	0.00223	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0017	0.00219	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	0.00163	0.0021	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00163	0.0021	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00161	0.00207	CbGpPWpGaD
Orphenadrine—KCNH2—Neuronal System—BRAF—adrenal gland cancer	0.00159	0.00204	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00154	0.00199	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00152	0.00195	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00148	0.00191	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00146	0.00188	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00146	0.00188	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0014	0.0018	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—EGFR—adrenal gland cancer	0.00134	0.00172	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—EGFR—adrenal gland cancer	0.00123	0.00158	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00123	0.00158	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—CTNNB1—adrenal gland cancer	0.0012	0.00155	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—EGFR—adrenal gland cancer	0.00119	0.00152	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—EGFR—adrenal gland cancer	0.00119	0.00152	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00116	0.00149	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00111	0.00142	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.0011	0.00141	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.00107	0.00138	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00107	0.00137	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—CTNNB1—adrenal gland cancer	0.00107	0.00137	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000995	0.00128	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000983	0.00126	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.00098	0.00126	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000979	0.00126	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000977	0.00126	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000973	0.00125	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—EGFR—adrenal gland cancer	0.00097	0.00125	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000963	0.00124	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.00096	0.00123	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—EGFR—adrenal gland cancer	0.000955	0.00123	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000938	0.00121	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	0.000898	0.00115	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000889	0.00114	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000884	0.00114	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—EGFR—adrenal gland cancer	0.000877	0.00113	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.000877	0.00113	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000875	0.00112	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CTNNB1—adrenal gland cancer	0.000873	0.00112	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000873	0.00112	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000863	0.00111	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000859	0.0011	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—EGFR—adrenal gland cancer	0.000846	0.00109	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—EGFR—adrenal gland cancer	0.000846	0.00109	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—EGFR—adrenal gland cancer	0.000833	0.00107	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000815	0.00105	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000802	0.00103	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0008	0.00103	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000794	0.00102	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000792	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000781	0.001	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00078	0.001	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000766	0.000985	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000754	0.000969	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	0.000751	0.000965	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—EGFR—adrenal gland cancer	0.000692	0.00089	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000631	0.000812	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000631	0.000812	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000618	0.000795	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000618	0.000795	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000606	0.00078	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.000605	0.000778	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000595	0.000765	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	0.000595	0.000765	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000569	0.000731	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00056	0.000719	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000531	0.000683	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000525	0.000675	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000523	0.000672	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000517	0.000664	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000508	0.000653	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000499	0.000642	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000498	0.00064	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000482	0.00062	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00048	0.000618	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000475	0.00061	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000473	0.000608	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000471	0.000605	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000468	0.000602	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000461	0.000593	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000461	0.000593	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000461	0.000592	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000454	0.000583	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000445	0.000572	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.00044	0.000566	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000433	0.000557	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000343	0.000442	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000342	0.000439	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000336	0.000432	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000336	0.000432	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000336	0.000432	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000331	0.000425	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.00031	0.000399	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000305	0.000393	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000287	0.000369	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000287	0.000369	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.000285	0.000366	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.00028	0.000361	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000278	0.000358	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000275	0.000353	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000273	0.000351	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GNAS—adrenal gland cancer	0.000273	0.000351	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000272	0.00035	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.00027	0.000347	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000268	0.000344	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	0.000268	0.000344	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000266	0.000341	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000261	0.000336	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000229	0.000294	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000225	0.000289	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000214	0.000275	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.000199	0.000256	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000196	0.000252	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000187	0.000241	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—adrenal gland cancer	0.000184	0.000236	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000183	0.000236	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000181	0.000233	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.00018	0.000232	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000178	0.000229	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000175	0.000226	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000173	0.000222	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000156	0.000201	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.000149	0.000192	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	0.000146	0.000188	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000131	0.000168	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000129	0.000166	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000126	0.000163	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000124	0.00016	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.000104	0.000133	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000102	0.000131	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	8.7e-05	0.000112	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	8.56e-05	0.00011	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—adrenal gland cancer	8.52e-05	0.00011	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.79e-05	8.73e-05	CbGpPWpGaD
